Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy

Clinical trial NCT05132738 · UNKNOWN

Trial details

NCT number: NCT05132738
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2021-08-01
Primary completion: 2023-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.